DDX24_HUMAN - dbPTM
DDX24_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID DDX24_HUMAN
UniProt AC Q9GZR7
Protein Name ATP-dependent RNA helicase DDX24
Gene Name DDX24
Organism Homo sapiens (Human).
Sequence Length 859
Subcellular Localization
Protein Description ATP-dependent RNA helicase..
Protein Sequence MKLKDTKSRPKQSSCGKFQTKGIKVVGKWKEVKIDPNMFADGQMDDLVCFEELTDYQLVSPAKNPSSLFSKEAPKRKAQAVSEEEEEEEGKSSSPKKKIKLKKSKNVATEGTSTQKEFEVKDPELEAQGDDMVCDDPEAGEMTSENLVQTAPKKKKNKGKKGLEPSQSTAAKVPKKAKTWIPEVHDQKADVSAWKDLFVPRPVLRALSFLGFSAPTPIQALTLAPAIRDKLDILGAAETGSGKTLAFAIPMIHAVLQWQKRNAAPPPSNTEAPPGETRTEAGAETRSPGKAEAESDALPDDTVIESEALPSDIAAEARAKTGGTVSDQALLFGDDDAGEGPSSLIREKPVPKQNENEEENLDKEQTGNLKQELDDKSATCKAYPKRPLLGLVLTPTRELAVQVKQHIDAVARFTGIKTAILVGGMSTQKQQRMLNRRPEIVVATPGRLWELIKEKHYHLRNLRQLRCLVVDEADRMVEKGHFAELSQLLEMLNDSQYNPKRQTLVFSATLTLVHQAPARILHKKHTKKMDKTAKLDLLMQKIGMRGKPKVIDLTRNEATVETLTETKIHCETDEKDFYLYYFLMQYPGRSLVFANSISCIKRLSGLLKVLDIMPLTLHACMHQKQRLRNLEQFARLEDCVLLATDVAARGLDIPKVQHVIHYQVPRTSEIYVHRSGRTARATNEGLSLMLIGPEDVINFKKIYKTLKKDEDIPLFPVQTKYMDVVKERIRLARQIEKSEYRNFQACLHNSWIEQAAAALEIELEEDMYKGGKADQQEERRRQKQMKVLKKELRHLLSQPLFTESQKTKYPTQSGKPPLLVSAPSKSESALSCLSKQKKKKTKKPKEPQPEQPQPSTSAN
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
4Ubiquitination----MKLKDTKSRPK
----CCCCCCCCCCC
58.8124816145
6Phosphorylation--MKLKDTKSRPKQS
--CCCCCCCCCCCCC
29.36-
17AcetylationPKQSSCGKFQTKGIK
CCCCCCCCCCCCCEE
38.3319608861
17UbiquitinationPKQSSCGKFQTKGIK
CCCCCCCCCCCCCEE
38.3319608861
21AcetylationSCGKFQTKGIKVVGK
CCCCCCCCCEEEEEE
48.1023749302
21UbiquitinationSCGKFQTKGIKVVGK
CCCCCCCCCEEEEEE
48.1033845483
24AcetylationKFQTKGIKVVGKWKE
CCCCCCEEEEEECEE
39.2725953088
28AcetylationKGIKVVGKWKEVKID
CCEEEEEECEEEECC
43.4126051181
54PhosphorylationLVCFEELTDYQLVSP
EEEHHHCCCCCCCCC
35.6228450419
56PhosphorylationCFEELTDYQLVSPAK
EHHHCCCCCCCCCCC
9.8628450419
60PhosphorylationLTDYQLVSPAKNPSS
CCCCCCCCCCCCHHH
27.9425159151
66PhosphorylationVSPAKNPSSLFSKEA
CCCCCCHHHCCCCCC
49.4128450419
67PhosphorylationSPAKNPSSLFSKEAP
CCCCCHHHCCCCCCC
34.3928450419
70PhosphorylationKNPSSLFSKEAPKRK
CCHHHCCCCCCCHHH
34.5728450419
71AcetylationNPSSLFSKEAPKRKA
CHHHCCCCCCCHHHC
51.0319608861
71UbiquitinationNPSSLFSKEAPKRKA
CHHHCCCCCCCHHHC
51.0332015554
82PhosphorylationKRKAQAVSEEEEEEE
HHHCCCCCHHHHHHC
42.1629255136
92PhosphorylationEEEEEGKSSSPKKKI
HHHHCCCCCCCCHHH
47.0723401153
93PhosphorylationEEEEGKSSSPKKKIK
HHHCCCCCCCCHHHE
54.8922167270
94PhosphorylationEEEGKSSSPKKKIKL
HHCCCCCCCCHHHEE
48.0722167270
104PhosphorylationKKIKLKKSKNVATEG
HHHEECCCCCCCCCC
28.0729083192
109PhosphorylationKKSKNVATEGTSTQK
CCCCCCCCCCCCCCE
30.5729083192
112PhosphorylationKNVATEGTSTQKEFE
CCCCCCCCCCCEEEE
23.5125159151
113PhosphorylationNVATEGTSTQKEFEV
CCCCCCCCCCEEEEE
39.4325159151
114PhosphorylationVATEGTSTQKEFEVK
CCCCCCCCCEEEEEC
43.4225159151
143PhosphorylationDPEAGEMTSENLVQT
CCCCCCCCHHHHHHC
28.69-
166PhosphorylationGKKGLEPSQSTAAKV
CCCCCCCCCCCCCCC
27.6417525332
172AcetylationPSQSTAAKVPKKAKT
CCCCCCCCCCCCCCC
57.5125953088
172UbiquitinationPSQSTAAKVPKKAKT
CCCCCCCCCCCCCCC
57.5129967540
178UbiquitinationAKVPKKAKTWIPEVH
CCCCCCCCCCCCHHC
53.9529967540
188AcetylationIPEVHDQKADVSAWK
CCHHCCCCCCHHHHH
53.2425953088
188UbiquitinationIPEVHDQKADVSAWK
CCHHCCCCCCHHHHH
53.2429967540
192PhosphorylationHDQKADVSAWKDLFV
CCCCCCHHHHHHHCC
29.0322817900
1952-HydroxyisobutyrylationKADVSAWKDLFVPRP
CCCHHHHHHHCCCHH
44.25-
195AcetylationKADVSAWKDLFVPRP
CCCHHHHHHHCCCHH
44.2526051181
195UbiquitinationKADVSAWKDLFVPRP
CCCHHHHHHHCCCHH
44.2521890473
208PhosphorylationRPVLRALSFLGFSAP
HHHHHHHHHHCCCCC
19.9024114839
213PhosphorylationALSFLGFSAPTPIQA
HHHHHCCCCCCHHHH
31.3824114839
2302-HydroxyisobutyrylationLAPAIRDKLDILGAA
HHHHHHHHCEEECEE
37.90-
230AcetylationLAPAIRDKLDILGAA
HHHHHHHHCEEECEE
37.9025953088
230UbiquitinationLAPAIRDKLDILGAA
HHHHHHHHCEEECEE
37.9029967540
268PhosphorylationRNAAPPPSNTEAPPG
HCCCCCCCCCCCCCC
63.2620068231
270PhosphorylationAAPPPSNTEAPPGET
CCCCCCCCCCCCCCC
37.5521406692
277PhosphorylationTEAPPGETRTEAGAE
CCCCCCCCCCCCCCC
49.1321406692
279PhosphorylationAPPGETRTEAGAETR
CCCCCCCCCCCCCCC
37.2923401153
285PhosphorylationRTEAGAETRSPGKAE
CCCCCCCCCCCCCHH
35.5925159151
287PhosphorylationEAGAETRSPGKAEAE
CCCCCCCCCCCHHHH
45.4829255136
290UbiquitinationAETRSPGKAEAESDA
CCCCCCCCHHHHCCC
46.5722817900
295PhosphorylationPGKAEAESDALPDDT
CCCHHHHCCCCCCCC
34.9229255136
302PhosphorylationSDALPDDTVIESEAL
CCCCCCCCEEECCCC
30.6629255136
306PhosphorylationPDDTVIESEALPSDI
CCCCEEECCCCCHHH
19.6229255136
311PhosphorylationIESEALPSDIAAEAR
EECCCCCHHHHHHHH
42.3623927012
320UbiquitinationIAAEARAKTGGTVSD
HHHHHHHHHCCCCCC
41.9921906983
342PhosphorylationDDAGEGPSSLIREKP
CCCCCCCCCHHCCCC
48.9425627689
343PhosphorylationDAGEGPSSLIREKPV
CCCCCCCCHHCCCCC
30.8325159151
370SumoylationKEQTGNLKQELDDKS
HHHHCCHHHHHCCCC
45.81-
370SumoylationKEQTGNLKQELDDKS
HHHHCCHHHHHCCCC
45.8128112733
381UbiquitinationDDKSATCKAYPKRPL
CCCCCCCCCCCCCCC
46.7529967540
394PhosphorylationPLLGLVLTPTRELAV
CCEEEEEECCHHHHH
18.3520068231
396PhosphorylationLGLVLTPTRELAVQV
EEEEEECCHHHHHHH
31.3820068231
4042-HydroxyisobutyrylationRELAVQVKQHIDAVA
HHHHHHHHHHHHHHH
21.04-
404UbiquitinationRELAVQVKQHIDAVA
HHHHHHHHHHHHHHH
21.0433845483
414PhosphorylationIDAVARFTGIKTAIL
HHHHHHHHCCCEEEE
32.2320860994
425SulfoxidationTAILVGGMSTQKQQR
EEEECCCCCHHHHHH
3.0121406390
429UbiquitinationVGGMSTQKQQRMLNR
CCCCCHHHHHHHHCC
48.7822505724
444PhosphorylationRPEIVVATPGRLWEL
CCCEEEECCCHHHHH
18.0528674419
453UbiquitinationGRLWELIKEKHYHLR
CHHHHHHHHHCHHHC
73.6429967540
4552-HydroxyisobutyrylationLWELIKEKHYHLRNL
HHHHHHHHCHHHCCH
44.45-
475MethylationLVVDEADRMVEKGHF
EEEEHHHHHHHHCCH
37.79-
503PhosphorylationQYNPKRQTLVFSATL
CCCCCCCCEEEEEEE
28.9920068231
507PhosphorylationKRQTLVFSATLTLVH
CCCCEEEEEEEEHHH
16.9220068231
509PhosphorylationQTLVFSATLTLVHQA
CCEEEEEEEEHHHHC
21.0520068231
511PhosphorylationLVFSATLTLVHQAPA
EEEEEEEEHHHHCCH
23.5220068231
532PhosphorylationHTKKMDKTAKLDLLM
HCCCCCHHHHHHHHH
25.4320068231
534AcetylationKKMDKTAKLDLLMQK
CCCCHHHHHHHHHHH
48.0025953088
541AcetylationKLDLLMQKIGMRGKP
HHHHHHHHHCCCCCC
27.5425953088
541UbiquitinationKLDLLMQKIGMRGKP
HHHHHHHHHCCCCCC
27.54-
547UbiquitinationQKIGMRGKPKVIDLT
HHHCCCCCCEEEECC
31.1624816145
549UbiquitinationIGMRGKPKVIDLTRN
HCCCCCCEEEECCCC
56.1429967540
567UbiquitinationVETLTETKIHCETDE
EEEEEECEEEEECCC
24.9929967540
601AcetylationANSISCIKRLSGLLK
HHHHHHHHHHHHHHH
52.1725953088
601UbiquitinationANSISCIKRLSGLLK
HHHHHHHHHHHHHHH
52.17-
624AcetylationLHACMHQKQRLRNLE
HHHHHHHHHHHHCHH
23.7825953088
624SumoylationLHACMHQKQRLRNLE
HHHHHHHHHHHHCHH
23.7828112733
624UbiquitinationLHACMHQKQRLRNLE
HHHHHHHHHHHHCHH
23.78-
655UbiquitinationARGLDIPKVQHVIHY
HCCCCCCCCEEEEEE
55.6633845483
700AcetylationPEDVINFKKIYKTLK
HHHHCCHHHHHHHHC
33.5024431627
700UbiquitinationPEDVINFKKIYKTLK
HHHHCCHHHHHHHHC
33.5021906983
701UbiquitinationEDVINFKKIYKTLKK
HHHCCHHHHHHHHCC
47.3222817900
703PhosphorylationVINFKKIYKTLKKDE
HCCHHHHHHHHCCCC
13.55-
704UbiquitinationINFKKIYKTLKKDED
CCHHHHHHHHCCCCC
51.3522817900
705PhosphorylationNFKKIYKTLKKDEDI
CHHHHHHHHCCCCCC
27.17-
708UbiquitinationKIYKTLKKDEDIPLF
HHHHHHCCCCCCCCC
70.2629967540
719PhosphorylationIPLFPVQTKYMDVVK
CCCCCCCCCHHHHHH
25.1129978859
7202-HydroxyisobutyrylationPLFPVQTKYMDVVKE
CCCCCCCCHHHHHHH
22.83-
720UbiquitinationPLFPVQTKYMDVVKE
CCCCCCCCHHHHHHH
22.8321906983
726UbiquitinationTKYMDVVKERIRLAR
CCHHHHHHHHHHHHH
40.9223503661
737UbiquitinationRLARQIEKSEYRNFQ
HHHHHHHHHHHHCHH
50.6624816145
769UbiquitinationELEEDMYKGGKADQQ
HCHHHHHCCCCHHHH
55.3322817900
772UbiquitinationEDMYKGGKADQQEER
HHHHCCCCHHHHHHH
58.4122817900
786UbiquitinationRRRQKQMKVLKKELR
HHHHHHHHHHHHHHH
41.7524816145
797PhosphorylationKELRHLLSQPLFTES
HHHHHHHCCCCCCCC
35.7923312004
804PhosphorylationSQPLFTESQKTKYPT
CCCCCCCCCCCCCCC
33.6428555341
806UbiquitinationPLFTESQKTKYPTQS
CCCCCCCCCCCCCCC
57.1522817900
807PhosphorylationLFTESQKTKYPTQSG
CCCCCCCCCCCCCCC
28.3328152594
808SumoylationFTESQKTKYPTQSGK
CCCCCCCCCCCCCCC
57.16-
808AcetylationFTESQKTKYPTQSGK
CCCCCCCCCCCCCCC
57.1625953088
808SumoylationFTESQKTKYPTQSGK
CCCCCCCCCCCCCCC
57.1628112733
808UbiquitinationFTESQKTKYPTQSGK
CCCCCCCCCCCCCCC
57.1622817900
809PhosphorylationTESQKTKYPTQSGKP
CCCCCCCCCCCCCCC
19.4228152594
811PhosphorylationSQKTKYPTQSGKPPL
CCCCCCCCCCCCCCE
32.0728152594
813PhosphorylationKTKYPTQSGKPPLLV
CCCCCCCCCCCCEEE
51.7928152594
815AcetylationKYPTQSGKPPLLVSA
CCCCCCCCCCEEEEC
49.0225953088
815UbiquitinationKYPTQSGKPPLLVSA
CCCCCCCCCCEEEEC
49.0229967540
821PhosphorylationGKPPLLVSAPSKSES
CCCCEEEECCCCCHH
34.1427251275
824PhosphorylationPLLVSAPSKSESALS
CEEEECCCCCHHHHH
48.8328555341
825AcetylationLLVSAPSKSESALSC
EEEECCCCCHHHHHH
58.1226051181
825SumoylationLLVSAPSKSESALSC
EEEECCCCCHHHHHH
58.1228112733
826PhosphorylationLVSAPSKSESALSCL
EEECCCCCHHHHHHH
40.9120068231
828PhosphorylationSAPSKSESALSCLSK
ECCCCCHHHHHHHHH
41.4220068231
831PhosphorylationSKSESALSCLSKQKK
CCCHHHHHHHHHHHC
16.8420068231
834PhosphorylationESALSCLSKQKKKKT
HHHHHHHHHHHCCCC
37.0525159151
835AcetylationSALSCLSKQKKKKTK
HHHHHHHHHHCCCCC
53.8725953088
835UbiquitinationSALSCLSKQKKKKTK
HHHHHHHHHHCCCCC
53.8733845483
857PhosphorylationEQPQPSTSAN-----
CCCCCCCCCC-----
30.1025627689

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
82SPhosphorylationKinaseCHEK1O14757
GPS
-KUbiquitinationE3 ubiquitin ligaseMDM2Q00987
PMID:24980433

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of DDX24_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of DDX24_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
BCS1_HUMANBCS1Lphysical
16169070
TRDMT_HUMANTRDMT1physical
16169070
EIF3E_HUMANEIF3Ephysical
16169070
MKS1_HUMANMKS1physical
16169070
HS90B_HUMANHSP90AB1physical
16169070
CENPR_HUMANITGB3BPphysical
16169070
PA1B3_HUMANPAFAH1B3physical
16169070
TPIS_HUMANTPI1physical
16169070
VDAC3_HUMANVDAC3physical
16169070
IF4A2_MOUSEEif4a2physical
16169070
GRP78_HUMANHSPA5physical
16169070
PIN1_HUMANPIN1physical
16169070
SPTN1_HUMANSPTAN1physical
16169070
GIT1_HUMANGIT1physical
16169070
DPOA2_HUMANPOLA2physical
16169070
RS25_HUMANRPS25physical
22939629
RPAC1_HUMANPOLR1Cphysical
22939629
INO80_HUMANINO80physical
22939629
DKC1_HUMANDKC1physical
22939629
DDX31_HUMANDDX31physical
22939629
GLRA2_HUMANGLRA2physical
21988832
BCCIP_HUMANBCCIPphysical
26344197
BRX1_HUMANBRIX1physical
26344197
DDX27_HUMANDDX27physical
26344197
DDX55_HUMANDDX55physical
26344197
DDX56_HUMANDDX56physical
26344197
FBRL_HUMANFBLphysical
26344197
SPB1_HUMANFTSJ3physical
26344197
GNL3_HUMANGNL3physical
26344197
GRWD1_HUMANGRWD1physical
26344197
NOG1_HUMANGTPBP4physical
26344197
INT6_HUMANINTS6physical
26344197
KRR1_HUMANKRR1physical
26344197
NH2L1_HUMANNHP2L1physical
26344197
MK67I_HUMANNIFKphysical
26344197
NOC2L_HUMANNOC2Lphysical
26344197
NOL6_HUMANNOL6physical
26344197
NOP2_HUMANNOP2physical
26344197
NOP56_HUMANNOP56physical
26344197
NSA2_HUMANNSA2physical
26344197
PESC_HUMANPES1physical
26344197
PWP1_HUMANPWP1physical
26344197
RBBP6_HUMANRBBP6physical
26344197
RPF2_HUMANRPF2physical
26344197
RL11_HUMANRPL11physical
26344197
RL15_HUMANRPL15physical
26344197
RL4_HUMANRPL4physical
26344197
RL6_HUMANRPL6physical
26344197
RS4X_HUMANRPS4Xphysical
26344197
RS7_HUMANRPS7physical
26344197
TBL3_HUMANTBL3physical
26344197
TSR2_HUMANTSR2physical
26344197
WDR12_HUMANWDR12physical
26344197
XRN1_HUMANXRN1physical
26344197
MDM2_MOUSEMdm2physical
24980433
NUCL_HUMANNCLphysical
24980433
NIP7_HUMANNIP7physical
24980433
COR1A_HUMANCORO1Aphysical
27173435
IFT57_HUMANIFT57physical
27173435

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of DDX24_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-17 AND LYS-71, AND MASSSPECTROMETRY.
Phosphorylation
ReferencePubMed
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-82; SER-94; SER-287 ANDSER-295, AND MASS SPECTROMETRY.
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-82, AND MASSSPECTROMETRY.
"Large-scale phosphoproteome analysis of human liver tissue byenrichment and fractionation of phosphopeptides with strong anionexchange chromatography.";
Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D.,Zou H., Gu J.;
Proteomics 8:1346-1361(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-82, AND MASSSPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-82; SER-94; SER-287;SER-295 AND THR-302, AND MASS SPECTROMETRY.
"Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis.";
Wang B., Malik R., Nigg E.A., Korner R.;
Anal. Chem. 80:9526-9533(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-82, AND MASSSPECTROMETRY.
"ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage.";
Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.;
Science 316:1160-1166(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-166, AND MASSSPECTROMETRY.
"A probability-based approach for high-throughput proteinphosphorylation analysis and site localization.";
Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
Nat. Biotechnol. 24:1285-1292(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-82, AND MASSSPECTROMETRY.
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks.";
Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.;
Cell 127:635-648(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-82 AND SER-192, AND MASSSPECTROMETRY.
"Large-scale characterization of HeLa cell nuclear phosphoproteins.";
Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-82 AND THR-302, AND MASSSPECTROMETRY.

TOP